Discover the considerations behind CSL Seqirus' shift to trivalent influenza vaccines, removing B/Yamagata strain. Gregg Sylvester, MD, MPH, explains the impact on effectiveness and steps for a seamless transition in health care facilities.
Mara Hofherr, PharmD, a clinical oncology pharmacist at Washington University, highlights key findings of the KEYNOTE-522 trial in comparison of outcomes between Black and White patients with triple-negative breast cancer.
Investigators note that prospective research is needed to confirm the efficacy of vitamin D supplements in preventing chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Viktor Grunwald, MD, PhD, discusses the post-hoc analysis of the phase 3 CLEAR trial investigating the combination treatment in the first-line setting for advanced renal cell carcinoma.